build career as Medical Affairs

How To Build A Successful Career As A Medical Affairs Professional

/in , , , , , , , , , /by

Objectives:

In this session, you will hear “insider tips” from three senior-level Medical Affairs leaders from leading multinational biopharma companies. The discussion will be broken into three practical sections:
1. How to advance your career in Medical Affairs;
2. What employers look for when hiring;
3. Competencies required for a modern Medical Affairs organization.

At the conclusion of this session, participants should:

  • • Be able to create a checklist of the key (basic and advanced) capabilities that managers and recruiters expect MA professionals to have experience and knowledge in
  • • Walk away with specific tips and expert advice to help develop a strategy to manage a successful career in the Medical Affairs field
  • • Discover the importance of gaining enough tenure in a specific role to acquire necessary breadth and experience as well as the value of building “social capital” within your organization to advance your career

Access Options

Launch Readiness 2020: Ensuring Strategy And Value From Global To Local Perspectives

Launch Readiness 2020: Ensuring Strategy And Value From Global To Local Perspectives

/in , , , , , , /by

Objectives:

What is Strategy Related to Launch?

  • • Medical Affairs Launch Readiness
  • • What is the role for Medical Affairs in launch readiness?
  • • Who is part of launch readiness and how is it accomplished?
  • • Execution of Global Strategic Plans at the Regional Level
  • • How do local affiliates impact the global strategy?
  • • Demonstrating Value & Impact for Medical Affairs
  • • What performance measures (KPIs) can we use to refine strategy?

Access Options

 

Professional Education, Capabilities and Identity in Medical Affairs

/in , , , , , , , , , /by

Objectives:

MA has seen an exponential growth over the last decade as it value and place within the pharmaceutical industry is being realised. The evolution of MA from a support function to strategic partner has changed the direction of MA and also required an evolution of skill sets for the roles which underpin MA.

As a profession, there is still a void with a globally recognised advanced scientific qualification, capability frameworks across the main 3 role types and accreditation.

This collaborative webinar aims to discuss available postgraduate courses and insights from alumni into how their qualification helped advance their understanding of pharmaceutical medicine and their career.

  • • Understand what educational opportunities are open to MA professionals and also those aspiring to enter the profession
  • • Comprehend the content of programmes and how it relates to roles
  • • Discuss the future of MA in terms of universal recognition of a base qualification which can then be regionally adapted

Access Options

57

Creating an Integrated Core Scientific Framework for Communicating to Diverse External Stakeholders: A Health Science Approach

/in , , /by

Objectives:

Medical Affairs professionals must engage with multiple stakeholders in healthcare delivery, including clinicians, patients, payers and policy makers. Each of these audiences is focused on different value drivers and requires specialized communications and messaging to make informed decisions. Traditional scientific communications platform (SCP) usage is usually limited to the Medical team. Internal functions focused on other audiences (e.g. payers, patients, policy makers) often create their own message frameworks, duplicating efforts and potentially leading to misalignment. Increasingly, audiences expect to be informed of the bigger picture and to contribute to the wider value story through direct interactions with other stakeholder groups. HealthScience brings together clinical, economic, social, behavioral and policy perspectives to demonstrate therapeutic value in healthcare systems. The HealthScience approach can be used to expand the concepts and content of the SCP to provide an integrated engagement plan and proposals for evidence generation. At the conclusion of this session, participants should:

  • • Evaluate the commonalities and differences in the use, structure and evolution of scientific communications platforms within and between companies
  • • Understand how a HealthScience approach can help to integrate insights, communications and evidence generation plans across multiple functions

Access Options

Strategic Planning_Standards for Medical Affairs

Medical Affairs Strategic Planning Guide and Templates

/in , , , , , , , , /by

Strategic Planning_Standards for Medical Affairs

Objectives:

The Medical Affairs teams demonstrate leadership and value each year through the annual strategic planning process that aligns all multifunctional MA competencies on common objectives needed to support the product and organization. A focused and cohesive medical strategy must be developed to navigate the complex therapeutic environment for each product – overcoming challenges, taking advantage of opportunities and filling any scientific or clinical gaps. A comprehensive and supportive tactical plan aligned to the medical strategy should define the activities that will provide the most impact and benefit to stakeholders in therapeutic space while taking the MA team one-step closer to achieving annual goals.

The MAPS Medical Affairs Strategic Planning Guide and Template has been developed to provide guidance and recommendations to selected components that comprise the strategic medical affairs planning for a product – including the situational analysis, medical strategy, tactical/operational planning, and medical plan summary.

Access Options

Understanding AI And ML And Potential Applications For Medical Affairs

Understanding AI and ML And Potential Applications For Medical Affairs

/in , , , , , , , /by

Objectives:

Understand the latest technologies—Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU). Understand the potential of these technologies to increase efficiencies, enhance effectiveness and potentially reduce compliance risk.

At the conclusion of this session, participants should:
• Better understand contemporary digital trends of Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU)

Access Options

27

Clinical Statistics for Non-Statisticians (Part 2 of 2)

/in , , , , , , , /by

Objectives:

This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.

Statistical analysis in clinical trials

– Null/alternative hypotheses

– Statistical assumptions (type I error, significance level, type II error, statistical power,)

– Hypothesis testing

– Statistical tests

Statistics used in RCTs

– Type of outcome measures (dichotomous, continuous, time-to-event)

– Statistics used for analysis of dichotomous data (relative risk, odds ratio, risk difference, NNT)

– Analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves)

Access Options

25

A Global Perspective on Conducting Early Access Programs

/in , , , , , , , /by

Objectives:

Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.

At the end of this webinar the participant will be able to:

  • • List the differences between an early access program and a clinical trial
  • • Compare the different types of early access programs
  • • Describe the components needed to implement an early access program
  • • Understand how local laws and regulations govern the conduct of an early access program
  • • Understand the benefits and drawbacks of conducting an early access program

Access Options

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS event and resource updates
MAPS Program Support Services
Policies and Positions